Association between sentinel lymph node excision with or without preoperative SPECT/CT and metastatic node detection and disease-free survival in melanoma

JAMA

Volumn 308, Issue 10, 2012, Pages 1007-1014

  Stoffels, Ingo ^a   Boy, Christian ^a   Pöppel, Thorsten ^a   Kuhn, Jasna ^a   Klötgen, Kerstin ^a   Dissemond, Joachim ^a   Schadendorf, Dirk ^a   Klode, Joachim ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MICROMETASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE METASTASIS;

EID: 84866120003     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/2012.jama.11030     Document Type: Article

References (34)

1. American Cancer Society. Cancer Facts & Figures 2011. http://www.cancer.org/Research/CancerFacts-Figures/index. Accessed December 1, 2011.
2. American Cancer Society. Melanoma Skin Cancer Overview. http://www.cancer.org/Cancer/SkinCancer-Melanoma/index. Accessed December 1, 2011.
3. Livingstone E, Windemuth-Kieselbach C, Eigentler TK, et al. A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up. Eur J Cancer. 2011;47(13):1977- 1989.
4. Balch CM. Surgical management of regional lymph nodes in cutaneous melanoma. J Am Acad Dermatol. 1980;3(5):511-524.
5. Gershenwald JE, Ross MI. Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med. 2011;364(18):1738-1745.
6. Satzger I, Völker B, Meier A, Kapp A, Gutzmer R. Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes. Ann Surg Oncol. 2008;15(6):1723-1732.
7. Morton RL, Howard K, Thompson JF. The costeffectiveness of sentinel node biopsy in patients withintermediate thickness primary cutaneous melanoma. Ann Surg Oncol. 2009;16(4):929-940.
8. Morton DL, Thompson JF, Cochran AJ, et al; MSLT Group. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355(13):1307-1317.
9. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17(3):976-983.
10. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19(16):3622-3634.
11. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199-6206.
12. Nieweg OE. False-negative sentinel node biopsy. Ann Surg Oncol. 2009;16(8):2089-2091.
13. Covarelli P, Tomassini GM, Simonetti S, et al. The single-photon emission computed tomography/computed tomography: a new procedure to perform the sentinel node biopsy in patients with head and neck melanoma. Melanoma Res. 2007;17(5):323-328.
14. Mar MV, Miller SA, Kim EE, Macapinlac HA. Evaluation and localization of lymphatic drainage and sentinel lymph nodes in patients with head and neck melanomas by hybrid SPECT/CT lymphoscintigraphic imaging. J Nucl Med Technol. 2007;35(1):10-16, quiz 17-20.
15. van der Ploeg IM, Valdés Olmos RA, Kroon BB, et al. The yield of SPECT/CT for anatomical lymphatic mapping in patients with melanoma. Ann Surg Oncol. 2009;16(6):1537-1542.
16. Chakera AH, Hesse B, Burak Z, et al; European Association of Nuclear Medicine-European Organisation for Research and. EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging. 2009;36(10):1713-1742.
17. Lerman H, Lievshitz G, Zak O, Metser U, Schneebaum S, Even-Sapir E. Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med. 2007;48(2):201-206.
18. Garbe C, Hauschild A, Volkenandt M, et al. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting. Melanoma Res. 2008;18(2):152-160.
19. Stoffels I, Dissemond J, Körber A, et al. Reliability and cost-effectiveness of sentinel lymph node excision under local anaesthesia versus general anaesthesia for malignant melanoma: a retrospective analysis in 300 patients with malignant melanoma AJCC Stages I and II. J Eur Acad Dermatol Venereol. 2011;25(3):306-310.
20. Klode J, Poeppel T, Boy C, et al. Advantages of preoperative hybrid SPECT/CT in detection of sentinel lymph nodes in cutaneous head and neck malignancies. J Eur Acad Dermatol Venereol. 2011;25(10):1213-1221.
21. Barthelmes L, Goyal A, Newcombe RG, McNeill F, Mansel RE; NEW START and ALMANAC study groups. Adverse reactions to patent blue V dye: The NEW START and ALMANAC experience. Eur J Surg Oncol. 2010;36(4):399-403.
22. Prieto VG, Clark SH. Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann Diagn Pathol. 2002;6(4):257-264.
23. Garbe C, Hauschild A, Volkenandt M, et al. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Res. 2007;17(6):393-399.
24. Veenstra HJ, Wouters MW, Kroon BB, Olmos RA, Nieweg OE. Less false-negative sentinel node procedures in melanoma patientswith experience and proper collaboration. J Surg Oncol. 2011;104(5):454-457.
25. Sondak VK, Zager JS. Who is to blame for falsenegative sentinel node biopsies in melanoma? Ann Surg Oncol. 2010;17(3):670-673.
26. Vermeeren L, Valdés Olmos RA, Klop WM, et al. SPECT/CT for sentinel lymph node mapping in head and neck melanoma. Head Neck. 2011;33(1):1-6.
27. van der Ploeg IM, Valdés Olmos RA, Kroon BB, Nieweg OE. The Hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer. World J Surg. 2008;32(9):1930-1934.
28. Leiter U, Buettner PG, Bohnenberger K, et al. Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement. Ann Surg Oncol. 2010;17(1):129-137.
29. Haerle SK, Stoeckli SJ. SPECT/CT for Lymphatic Mapping of Sentinel Nodes in Early Squamous Cell Carcinoma of the Oral Cavity and Oropharynx. Int J Mol Imaging. 2011;2011:106068.
30. Gershenwald JE, Andtbacka RH, Prieto VG, et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol. 2008;26(26):4296-4303.
31. van der Ploeg AP, van Akkooi AC, Rutkowski P, et al. Prognosis in patients with sentinel nodepositive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. J Clin Oncol. 2011;29(16):2206-2214.
32. van Akkooi AC, Verhoef C, Eggermont AM. Importance of tumor load in the sentinel node in melanoma: clinical dilemmas. Nat Rev Clin Oncol. 2010;7(8):446-454.
33. RossMI. Sentinel node biopsy for melanoma: an update after two decades of experience. Semin Cutan Med Surg. 2010;29(4):238-248.
34. Vlymen JV. Outpatient anesthesia. In: Miller R, ed. Anesthesia. Vol 5. Philadelphia, PA: Churchill Livingston; 2000:2213-2240.